QT
ADMA icon

Quantbot Technologies’s ADMA Biologics ADMA Stock Holding History

Quantbot Technologies’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$50.9K Sell
6,079
-13,824
-69% -$126K ﹤0.01% 1636
2026
Q1 		$179K Buy
19,903
+3,546
+22% +$56K 0.01% 1200
2025
Q4 		$298K Buy
+16,357
New +$276K 0.01% 1118

Other funds holding ADMA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Quantbot Technologies's ADMA Position: Q2 2026 in Review

Quantbot Technologies reduced its ADMA Biologics (ADMA) stake by 69% in Q2 2026, selling an estimated $126K and leaving 6,079 shares worth $50.9K. The position accounts for ﹤0.01% of the portfolio, ranked #1636.

Quantbot Technologies first reported a position in ADMA in Q4 2025 and has held it in 3 quarters since. The position peaked at $298K in Q4 2025. 322 funds tracked by Wall St. Rank hold ADMA as of Q2 2026.

  • Quantbot Technologies held 6,079 shares of ADMA Biologics worth $50.9K as of Q2 2026.
  • Quantbot Technologies sold 13,824 ADMA Biologics shares in Q2 2026, an estimated $126K.
  • ADMA Biologics made up ﹤0.01% of Quantbot Technologies's portfolio in Q2 2026, its #1636 holding.
  • Quantbot Technologies first reported a position in ADMA Biologics in Q4 2025 and has held it in 3 quarters since.
  • Quantbot Technologies's ADMA Biologics position peaked at $298K in Q4 2025.
  • 322 funds tracked by Wall St. Rank held ADMA Biologics as of Q2 2026.

Based on Quantbot Technologies's 13F filing for Q2 2026, filed 12 Aug 2026.